Lupin Ltd (LUPN)

740.00 -7.20 (-0.96%)
Close INR Disclaimer

Lupin Ltd Company Profile

Equity Type
Lupin Limited is an India-based pharmaceutical company. The Company develops and commercializes a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) in over 100 markets in the United States, India, South Africa, and across the Asia Pacific, Latin America, and others. It offers vitamins, minerals, supplements and neurological products. It has presence in the cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastro-intestinal, anti-infectives and nonsteroidal anti-inflammatory drug therapy segments. Its complex generics portfolio includes Filgrastim, Peg-Filgrastim, Etanercept and Albuterol, and others. Its biosimilar products include Filgrastim, Peg-Filgrastim and Etanercept. Its specialty products consist of Solosec and NaMuscla. Its over-the-counter products include Softovac, Lupizyme, Aptivate, Lupisafe, Be One and V-Bath, and others. It supplies APIs for anti-retroviral, anti-malarial and others.
Contact Information
Off. Western Expressway Highway Santacruz (East) Mumbai,400055 India
91 22 6640 2323
91 22 2652 8806
Top Executives
Manju Deshbandhu Gupta 77 2017 Non-Executive Chairman of the Board
Vinita D. Gupta 53 2003 CEO & Executive Director
Nilesh Deshbandhu Gupta 0 2006 MD & Executive Director
Jean-Luc Belingard 74 2015 Independent Non-Executive Director
Punita Kumar-Sinha 60 2020 Independent Director
Kanwar Bir Singh Anand 67 2020 Independent Director
Ramesh Swaminathan 57 2007 Global CFO, Head Corporate Affairs & Executive Director
Mark D. McDade 68 2021 Independent Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles